DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines

BACKGROUND: The emerging use of direct oral anticoagulants (DOAC) in the management of cancer-associated venous thromboembolism (CAT) is significantly improving therapeutic adherence and quality of life. Despite this, many conditions can restrict the therapeutic index of these drugs. For all these r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cominacini, Mattia, Suardi, Silvia, Ferrari, Giulia, Ciresa, Roberto, Tosi, Federica, De Marchi, Sergio, Valenti, Maria Teresa, Dalle Carbonare, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356843/
https://www.ncbi.nlm.nih.gov/pubmed/36577902
http://dx.doi.org/10.1007/s00432-022-04535-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356843/
https://www.ncbi.nlm.nih.gov/pubmed/36577902
http://dx.doi.org/10.1007/s00432-022-04535-8

Ejemplares similares